Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis

Derek D C Ireland, Trinh Bang, Takashi Komatsu, Carol Shoshkes Reiss

Research output: Contribution to journalArticle

Abstract

Vesicular stomatitis virus (VSV) applied intranasally to mice initially infects the olfactory receptor neurons, and then spreads quickly to the rest of the central nervous system (CNS). Previously, we have shown that the cytokine interleukin-12 (IL-12) has a significant survival and recovery promoting effect in mice infected with VSV when administered at the time of infection. The question of whether IL-12 is efficacious under the more clinically relevant condition of post-infection administration was explored. The data show that when IL-12 is administered post-infection, it is as effective as at the time of infection.

Original languageEnglish (US)
Pages (from-to)35-40
Number of pages6
JournalViral Immunology
Volume12
Issue number1
StatePublished - 1999

Fingerprint

Viral Encephalitis
Interleukin-12
Vesicular Stomatitis
Infection
Olfactory Receptor Neurons
Viruses
Central Nervous System
Cytokines

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis. / Ireland, Derek D C; Bang, Trinh; Komatsu, Takashi; Reiss, Carol Shoshkes.

In: Viral Immunology, Vol. 12, No. 1, 1999, p. 35-40.

Research output: Contribution to journalArticle

@article{6109516b7ad84eab9a587878c81c63a9,
title = "Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis",
abstract = "Vesicular stomatitis virus (VSV) applied intranasally to mice initially infects the olfactory receptor neurons, and then spreads quickly to the rest of the central nervous system (CNS). Previously, we have shown that the cytokine interleukin-12 (IL-12) has a significant survival and recovery promoting effect in mice infected with VSV when administered at the time of infection. The question of whether IL-12 is efficacious under the more clinically relevant condition of post-infection administration was explored. The data show that when IL-12 is administered post-infection, it is as effective as at the time of infection.",
author = "Ireland, {Derek D C} and Trinh Bang and Takashi Komatsu and Reiss, {Carol Shoshkes}",
year = "1999",
language = "English (US)",
volume = "12",
pages = "35--40",
journal = "Viral Immunology",
issn = "0882-8245",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Delayed administration of interleukin-12 is efficacious in promoting recovery from lethal viral encephalitis

AU - Ireland, Derek D C

AU - Bang, Trinh

AU - Komatsu, Takashi

AU - Reiss, Carol Shoshkes

PY - 1999

Y1 - 1999

N2 - Vesicular stomatitis virus (VSV) applied intranasally to mice initially infects the olfactory receptor neurons, and then spreads quickly to the rest of the central nervous system (CNS). Previously, we have shown that the cytokine interleukin-12 (IL-12) has a significant survival and recovery promoting effect in mice infected with VSV when administered at the time of infection. The question of whether IL-12 is efficacious under the more clinically relevant condition of post-infection administration was explored. The data show that when IL-12 is administered post-infection, it is as effective as at the time of infection.

AB - Vesicular stomatitis virus (VSV) applied intranasally to mice initially infects the olfactory receptor neurons, and then spreads quickly to the rest of the central nervous system (CNS). Previously, we have shown that the cytokine interleukin-12 (IL-12) has a significant survival and recovery promoting effect in mice infected with VSV when administered at the time of infection. The question of whether IL-12 is efficacious under the more clinically relevant condition of post-infection administration was explored. The data show that when IL-12 is administered post-infection, it is as effective as at the time of infection.

UR - http://www.scopus.com/inward/record.url?scp=0032945378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032945378&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 35

EP - 40

JO - Viral Immunology

JF - Viral Immunology

SN - 0882-8245

IS - 1

ER -